Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.225
+0.235 (7.86%)
At close: Nov 18, 2026, 4:00 PM EST
3.280
+0.055 (1.71%)
After-hours: Nov 18, 2026, 7:42 PM EST
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $339.06 million as of November 18, 2026. It is the 17,373rd most valuable company in the world and the 3,078th biggest in the United States. Its market cap has increased by 12.22% in one year.
Market Cap
339.06M
Enterprise Value
215.18M
1-Year Change
12.22%
Global Rank
Country Rank
#3,078 United States
Category
ChartMarket Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $339.06M, an increase of 199.04%. That is a compound annual growth rate of 18.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 339.06M | 3.97% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 330.85M |
| ProKidney | 314.48M |
| Enanta Pharmaceuticals | 310.77M |
| Benitec Biopharma | 308.46M |
| Galectin Therapeutics | 304.57M |
| Autolus Therapeutics | 303.63M |
| Altimmune | 303.56M |
| Kyverna Therapeutics | 300.94M |